Molecular Templates Garners $8,500,000 Series C Funding
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1bf94590-c278-44c0-8d68-e296a3fe509e
Date 10/8/2013
Company Name Molecular Templates
Mailing Address 111 W. Cooperative Way Georgetown, TX 78626
Company Description Molecular Templates Inc. is creating an entirely new generation of potent anti-cancer agents based on proprietary applied proteomics technologies.The novel therapeutic agents in development by MTI are aimed particularly at melanoma, prostate and other metastatic cancers.
Proceeds Purposes This round of financing will allow us to develop our technology around antibody-drug conjugates, siRNA delivery, and enzyme replacement therapy while continuing to advance our lead compound, MT-3724.